The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 7 Mar 2006
doi: 10.1242/jcs.02850
Research Article
The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes
Muriel Mari,
Pascale Monzo,
Vincent Kaddai,
Frédérique Keslair,
Teresa Gonzalez,
Yannick Le Marchand-Brustel,
and
Mireille Cormont*
* Author for correspondence (e-mail: cormont{at}unice.fr)
Insulin regulates glucose uptake in the adipocytes by modulating Glut 4 localization, a traffic pathway involving the endocytic small GTPases Rab4, Rab5, and Rab11. The expression of the Rab4 effector Rabip4 leads to a 30% increase in glucose uptake and Glut 4 translocation in the presence of insulin, without modifications in the basal condition. This effect was not due to modifications of Glut 4 expression or insulin signaling, suggesting that Rabip4 controls Glut 4 trafficking. We present evidence that Rabip4 defines a subdomain of early endosomes and that Rabip4 is redistributed to the plasma membrane by insulin. Rabip4 is mostly absent from structures positive for early endosome antigen 1, Rab11 or transferrin receptors and from Glut 4 sequestration compartments. However, Rabip4 vesicles can be reached by internalized transferrin and Glut 4. Thus, Rabip4 probably defines an endocytic sorting platform for Glut 4 towards its sequestration pool. The expression of a form of Rabip4 unable to bind Rab4 does not modify basal and insulin-induced glucose transport. However, it induces an increase in the amount of Glut 4 at the plasma membrane and perturbs Glut 4 traffic from endosomes towards its sequestration compartments. These observations suggest that the uncoupling between Rabip4 and Rab4 induces the insertion of Glut 4 molecules that are unable to transport glucose into the plasma membrane.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. E Leney and J. M Tavare
The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets
J. Endocrinol.,
October 1, 2009;
203(1):
1 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Kaddai, T. Gonzalez, M. Bolla, Y. Le Marchand-Brustel, and M. Cormont
The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab,
July 1, 2008;
295(1):
E162 - E169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. I. Welsh, S. E. Leney, B. Lloyd-Lewis, M. Wherlock, A. J. Lindsay, M. W. McCaffrey, and J. M. Tavare
Rip11 is a Rab11- and AS160-RabGAP-binding protein required for insulin-stimulated glucose uptake in adipocytes
J. Cell Sci.,
December 1, 2007;
120(23):
4197 - 4208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bertola, S. Bonnafous, M. Cormont, R. Anty, J.-F. Tanti, A. Tran, Y. Le Marchand-Brustel, and P. Gual
Hepatocyte Growth Factor Induces Glucose Uptake in 3T3-L1 Adipocytes through A Gab1/Phosphatidylinositol 3-Kinase/Glut4 Pathway
J. Biol. Chem.,
April 6, 2007;
282(14):
10325 - 10332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jager, T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti
Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
Endocrinology,
January 1, 2007;
148(1):
241 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vukmirica, P. Monzo, Y. Le Marchand-Brustel, and M. Cormont
The Rab4A Effector Protein Rabip4 Is Involved in Migration of NIH 3T3 Fibroblasts
J. Biol. Chem.,
November 24, 2006;
281(47):
36360 - 36368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Barres, T. Gremeaux, P. Gual, T. Gonzalez, J. Gugenheim, A. Tran, Y. Le Marchand-Brustel, and J.-F. Tanti
Enigma Interacts with Adaptor Protein with PH and SH2 Domains to Control Insulin-Induced Actin Cytoskeleton Remodeling and Glucose Transporter 4 Translocation
Mol. Endocrinol.,
November 1, 2006;
20(11):
2864 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2006